Figure 3.
OS according to initial t-MN therapy. HMA, hypomethylating agent (azacitidine or decitabine).

OS according to initial t-MN therapy. HMA, hypomethylating agent (azacitidine or decitabine).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal